Associate Professor Lee Chi-Hang, Ronald
MBBS, MD, FRCP (Edin), FAMS, FACC, FSCAI
Senior Consultant Department of Cardiology, NUHCS
Associate Professor Department of Medicine, Yong Loo Lin School of Medicine, NUS
A/Prof. Ronald Lee Chi-Hang is an interventional cardiologist at the National University Heart Centre Singapore, and a tenured Associate Professor (clinician-scholar track) at the National University of Singapore. His recent research interest includes effects of sleep-disordered breathing on cardiovascular disease.
A/Prof. Lee graduated MBBS, and subsequently obtained a doctorate from the University of Hong Kong. He underwent his training in internal medicine and cardiology at the Queen Mary Hospital and Grantham Hospital (Hong Kong), Erasmus Medical Centre (Rotterdam, the Netherlands), and the Massachusetts General Hospital (Boston, USA). A/Prof. Lee’s honours include the Singapore Cardiac Society Young Investigator Award (2010), National Medical Excellence Award (2011), Clinician Scientist Award (2015), and Senior Clinician Scientist Award (2018). A/Prof. Lee has been appointed Associate Professor of Medicine by the National University of Singapore since 2007, and Senior Consultant Cardiologist by the National University Heart Centre Singapore since 2011.
A/Prof. Lee has authored or co-authored more than 170 articles in peer-reviewed journals. A/Prof. Lee has been awarded research grants from the National Medical Research Council, Ministry of Education, Singapore Heart Foundation and medical device industry. A/Prof. Lee is also noted for his passion for medical education. He is the founding course director of the Cardiology Review Course for Undergraduate Medical Students and is a core faculty member of the Cardiology Senior Residency Programme. He supervises research fellows and postgraduate students from Singapore and overseas. A/Prof. Lee is a fellow of the Royal College of Physician, American College of Cardiology, and Society for Cardiovascular Angiography and Interventions.
- Percutaneous Coronary Intervention
- Intravascular Ultrasound
- Sleep-disordered breathing
Specializes in Diseases and Conditions:
- Coronary Artery Disease
- Acute Coronary Syndrome
- Koo CY, Drager LF, Sethi R, Ho HH, Hein T, Jim MH, Tai BC, Zhang JJ, Lee CH. Obstructive Sleep Apnea and Diabetes Independently Add to Cardiovascular Risk After Coronary Revascularization. Sleep and Stent Study Investigators. Diabetes Care. 2018; 41: e12-e14.
- Lee CH, Sethi R, Li R, Ho HH, Hein T, Jim MH, Loo G, Koo CY, Gao XF, Chandra S, Yang XX, Furlan SF, Ge Z, Mundhekar A, Zhang WW, Uchôa CH, Kharwar PB, Chan PO, Chen SL, Chan MY, Richards AM, Tan HC, Ong TH, Roldan G, Tai BC, Drager LF, Zhang JJ. Obstructive Sleep Apnea and Cardiovascular Events after Percutaneous Coronary Intervention. Circulation 2016; 133: 2008-17.
- Zhao LP, Kofidis T, Chan SP, Ong TH, Yeo TC, Tan HC, Lee CH. Sleep Apnea and Re-admission in Patients Scheduled for Coronary Artery Bypass Surgery. Atherosclerosis 2015; 242: 128-134.
- Tan AY, Hau W, Ho HH, Ghaem Maralani H, Loo G, Khoo SM, Tai BC, Richards AM, Ong P, Lee CH. Obstructive Sleep Apnea and Coronary Plaque Characteristics. Chest. 2014; 145: 322-30.
- Lee CH, Khoo SM, Tai BC, Chong EY, Lau C, Than Y, Shi DX, Lee LC, Kailasam A, Low AF, Teo SG, Tan HC. Obstructive Sleep Apnea in Patients Admitted for Acute Myocardial Infarction: Prevalence, Predictors, and Effect on Microvascular Perfusion. Chest. 2009; 135: 1488-95.
- Lee CH, Tan HC, Wong HB, Zhang XL, Fun S, Gay M, Qu L, Lim J, Low A, Lim YT. Incidence, predictors and outcomes of Device Failure of X-sizer thrombectomy. Experience of 200 cases in 5 years. Am Heart J. 2007; 153: e13-9.
- Lee CH, Low A, Tai BC, Co M, Chan M, Lim J, Lim YT, Tan HC. Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention- a prospective randomized study. Eur Heart J. 2007; 28: 19-25.
- Lee CH, de Feyter P, Serruys PW, Saia F, Lemos PA, Goedhart D, Soares PR, Umans VA, Ciccone, Cortellaro M, Rutsch W, Legrand V. Beneficial effects of fluvastatin following percutaneous coronary intervention in patients presented with unstable versus stable angina. Results from the Lescol Intervention Prevention Study (LIPS). Heart. 2004; 90: 1156-61.
- Lemos PA, Lee CH, Degertekin M, Saia F, Tanabe K, Arampatzis CA, Hoye A, van Duuren M, Sianos G, Smits PC, de Feyter P, van der Giessen WJ, van Domburg RT, Serruys PW. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. J Am Coll Cardiol. 2003; 41: 2093-9.
- Kay J, Chow WH, Chan TM, Lo SK, Kwok OH, Yip A, Fan K, Lee CH, Lam WF. A randomized controlled study on acetylcysteine in preventing acute deterioration of renal function following elective coronary angiogram and intervention. JAMA. 2003; 289: 553-8.
For more publications, click here.
Back to Top